DrugPatentWatch Database Preview

Celltrion Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CELLTRION, and what generic and branded alternatives to CELLTRION drugs are available?

CELLTRION has seventeen approved drugs.

Summary for Celltrion

US Patents:	0
Tradenames:	16
Ingredients:	16
NDAs:	17
Patent Litigation for Celltrion:	See patent lawsuits for Celltrion
PTAB Cases with Celltrion as petitioner:	See PTAB cases with Celltrion as petitioner

Drugs and US Patents for Celltrion

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Celltrion	PREGABALIN	pregabalin	CAPSULE;ORAL	212865-002	Mar 20, 2020	AB	RX	No	No
Celltrion	PIOGLITAZONE HYDROCHLORIDE	pioglitazone hydrochloride	TABLET;ORAL	076798-001	Oct 26, 2012	AB	RX	No	No
Celltrion	LAMOTRIGINE	lamotrigine	TABLET;ORAL	078982-002	Jan 27, 2009		DISCN	No	No
Celltrion	RISPERIDONE	risperidone	TABLET;ORAL	078871-001	Oct 9, 2008	AB	RX	No	No
Celltrion	MEMANTINE HYDROCHLORIDE	memantine hydrochloride	TABLET;ORAL	090073-001	Sep 4, 2015	AB	RX	No	No
Celltrion	LEVOFLOXACIN	levofloxacin	TABLET;ORAL	090367-003	Jun 20, 2011	AB	RX	No	No
Celltrion	PREGABALIN	pregabalin	CAPSULE;ORAL	212865-001	Mar 20, 2020	AB	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Celltrion